
Gufic Biosciences Limited has informed the Exchange about press release dated 06-Jun-2022 titled Gufic Biosciences Limited eyes to grab major share of Rs. 3000 Crore Lyophilized Antibiotics and Antifungal market in India
Filed with NSE ·

Gufic Biosciences Limited has informed the Exchange about press release dated 06-Jun-2022 titled Gufic Biosciences Limited eyes to grab major share of Rs. 3000 Crore Lyophilized Antibiotics and Antifungal market in India
6ix hasn’t read this filing yet.
Gufic Biosciences Limited on 6ix
Follow Gufic Biosciences into a list and get an email when it puts out news.
Follow Gufic Biosciences